EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies

Georgios D Panos iD, Arun Lakshmanan, Panagiotis Dadoukis, Matteo Ripa iD, Lorenzo Motta, Winfried M Amoaku

Drug Design, Development and Therapy · 2023-09 · Volume 17 · 2861-2873

DOI: 10.2147/dddt.s427416 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2023-09. Verfasst von Georgios D Panos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Queen's Medical Centre, Nottingham University Hospitals, Nottingham, UK. Hauptthemen laut MEDLINE: Wet Macular Degeneration, Macular Edema, Diabetic Retinopathy. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wet Macular DegenerationMacular EdemaDiabetic RetinopathyHumansVascular Endothelial Growth Factor ARanibizumabAngiogenesis InhibitorsBevacizumabReceptors, Vascular Endothelial Growth FactorVisual AcuityIntravitreal InjectionsAntibodies, Bispecific

Stichwörter der Autor:innen

age-related macular degenerationanti-VEGFdegenerative macular disordersdiabetic macular oedemadiabetic retinopathyefficacyfaricimabintravitreal treatmentretinal vein occlusionsafety

Substanzen

Vascular Endothelial Growth Factor ARanibizumabAngiogenesis InhibitorsBevacizumabReceptors, Vascular Endothelial Growth FactorfaricimabAntibodies, Bispecific

Autor:innen und Institutionen

  • Department of Ophthalmology, Queen's Medical Centre, Nottingham University Hospitals, Nottingham, UK.
  • Division of Ophthalmology and Visual Sciences, Faculty of Medicine & Health Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
  • Eye Treatment Centre, Whipps Cross University Hospital, Barts Health NHS Trust, London, UK.
  • Department of Ophthalmology, William Harvey Hospital, East Kent Hospitals University NHS Foundation Trust, Kent, UK.

ORCID-Profile: Georgios D Panos, Matteo Ripa

Zitieren

APA

Panos, G. D., Lakshmanan, A., Dadoukis, P., Ripa, M., Motta, L., & Amoaku, W. M. (2023). Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies. Drug Design, Development and Therapy, Volume 17, 2861-2873. https://doi.org/10.2147/dddt.s427416

Vancouver

Panos GD, Lakshmanan A, Dadoukis P, Ripa M, Motta L, Amoaku WM. Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies. Drug Design, Development and Therapy. 2023;Volume 17:2861-2873. doi:10.2147/dddt.s427416

BibTeX
@article{Panos2023,
  author = {Panos, Georgios D and Lakshmanan, Arun and Dadoukis, Panagiotis and Ripa, Matteo and Motta, Lorenzo and Amoaku, Winfried M},
  title = {Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  volume = {Volume 17},
  pages = {2861--2873},
  doi = {10.2147/dddt.s427416}
}
Kostenlos starten →